<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02980952</url>
  </required_header>
  <id_info>
    <org_study_id>157758/03</org_study_id>
    <nct_id>NCT02980952</nct_id>
  </id_info>
  <brief_title>Amino Acid Balance During Physical Inactivity</brief_title>
  <official_title>Amino Acid Balance During Physical Inactivity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Exeter</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Exeter</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to assess the impact of physical inactivity on muscle amino acid balance. In
      addition, we will evaluate how the diet and/or a pharmacological intervention designed to
      manipulate lipid metabolism (acipimox) will modulate muscle amino acid balance.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle amino acid balance</measure>
    <time_frame>3 hours</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Assessing Muscle Amino Acid Balance</condition>
  <arm_group>
    <arm_group_label>Eucaloric + placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Fed in energy balance with a placebo supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Eucaloric + acipimox</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fed in energy balance with an acipimox supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypercaloric + placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fed in energy surplus with a placebo supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypercaloric + acipimox</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fed in energy surplus with an acipimox supplement</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>overfeeding</intervention_name>
    <arm_group_label>Hypercaloric + placebo</arm_group_label>
    <arm_group_label>Hypercaloric + acipimox</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acipimox</intervention_name>
    <description>Acipimox ingestion</description>
    <arm_group_label>Eucaloric + acipimox</arm_group_label>
    <arm_group_label>Hypercaloric + acipimox</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical inactivity</intervention_name>
    <arm_group_label>Eucaloric + placebo</arm_group_label>
    <arm_group_label>Eucaloric + acipimox</arm_group_label>
    <arm_group_label>Hypercaloric + placebo</arm_group_label>
    <arm_group_label>Hypercaloric + acipimox</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Eucaloric</intervention_name>
    <arm_group_label>Eucaloric + placebo</arm_group_label>
    <arm_group_label>Eucaloric + acipimox</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Eucaloric + placebo</arm_group_label>
    <arm_group_label>Hypercaloric + placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Hypercaloric</intervention_name>
    <arm_group_label>Hypercaloric + placebo</arm_group_label>
    <arm_group_label>Hypercaloric + acipimox</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI between 18 and 30

        Exclusion Criteria:

          -  On medication

          -  Family history of metabolic disease

          -  Diagnosed with any metabolic or cardiovascular conditions

          -  BMI &lt;18 or &gt;30

          -  Allergic to acipimox
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Benjamin T Wall, PhD</last_name>
    <phone>+4413927224774</phone>
    <phone_ext>4774</phone_ext>
    <email>b.t.wall@exeter.ac.uk</email>
  </overall_contact>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2016</study_first_submitted>
  <study_first_submitted_qc>December 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2016</study_first_posted>
  <last_update_submitted>December 1, 2016</last_update_submitted>
  <last_update_submitted_qc>December 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acipimox</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

